MRESVIA is an mRNA vaccine that's used to protect adults 60 years and older from illness caused by respiratory syncytial virus (RSV). This vaccine is injected into the muscle by a trained healthcare professional (HCP), and you only need to get one dose. Some potential side effects of the MRESVIA RSV vaccine include pain at the injection site, tiredness, headache, and muscle pain.
Prevention of illness caused by respiratory syncytial virus (RSV)
MRESVIA is an mRNA vaccine. This vaccine contains lab-made mRNA (genetic information) that teaches your body to make a part of a protein found on RSV.
Your immune system recognizes that this harmless protein doesn't belong in your body. This causes your immune system to make antibodies against the protein. The antibodies tell other immune cells to get rid of it.
Your immune system learns what the RSV protein looks like. So when you get infected with RSV, your immune system is ready to fight and protect you from infection.
Source: FDA
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Given as a single dose
Lowers the risk of RSV-related illness by up to 84% in people 60 years and older
Offers protection against RSV-A and RSV-B, two types of the virus
Only available as an injection, which might be uncomfortable
Can cause temporary side effects such as headache and muscle aches
Not approved for people younger than 60 years old
Discuss your full medical history with your primary care provider before you get vaccinated with MRESVIA. This vaccine might not work as well for you if you have conditions (or are taking medications) that weaken your immune system.
For MRESVIA to be most effective, you should get it during late summer or early fall, just before the start of RSV season. Ask your primary care provider about the best time for you to get your vaccine.
After getting the MRESVIA vaccine, stay seated for a few minutes. Vaccines that are injected, like MRESVIA, can sometimes cause fainting.
Share your vaccination record with a healthcare professional so they can help you get up to date with all of your vaccines.
Tell your primary care provider or pharmacist if you experience any side effects from MRESVIA. You can also report side effects to the Vaccine Adverse Event Reporting System at 1-800-822-7967 and www.vaers.hhs.gov.
MRESVIA can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Although rare, it's possible for MRESVIA to cause a severe allergic reaction. Get medical help right away if you experience tightness in your chest; trouble breathing; skin rash; or swelling in your lips, tongue, throat, or face after you get your MRESVIA shot.
Some people might feel faint after they get injectable vaccines like MRESVIA. To lower your risk of fainting, stay seated for a while after your vaccination and stand up slowly to make sure you don't fall.
Risk factors: Medical conditions that weaken the immune system | Taking medications that weaken your immune system
MRESVIA might not work as well for people with a weakened immune system. Talk to your primary care provider before you get vaccinated with MRESVIA if you have a medical condition that lowers the immune system, such as human immunodeficiency virus (HIV) or cancer. Also speak with your primary care provider if you take medications that weaken your immune system, like high-dose corticosteroids or transplant medications).
Dosage | Quantity | Price as low as | Price per unit |
---|---|---|---|
0.5ml prefilled syringe | 1 carton | $292.36 | $292.36 |
Adults ages 60 years and older: The typical dose is 0.5 mL injected into the muscle by a healthcare professional.
Prevention of illness caused by respiratory syncytial virus (RSV)
Prevention of illness caused by respiratory syncytial virus (RSV)
Adults ages 60 years and older
Pregnant females between 32 to 36 weeks of pregnancy
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Centers for Disease Control and Prevention. (2024). Fainting and vaccines.
Centers for Disease Control and Prevention. (2024). Healthcare providers: RSV vaccination for adults 60 years of age and over.
Centers for Disease Control and Prevention. (2024). RSV vaccines.
MedlinePlus. (2022). What are mRNA vaccines and how do they work?
Moderna, Inc. (2024). Moderna receives U.S. FDA approval for RSV vaccine mRESVIA(R). AccessWire.
ModernaTX, Inc. (2024). MRESVIA™ (respiratory syncytial virus vaccine) injectable suspension, for intramuscular use [package insert].
Wilson, E., et al. (2023). Efficacy and safety of an mRNA-based RSV PreF vaccine in older adults. The New England Journal of Medicine.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.